BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9197328)

  • 1. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM; Gerhartz HH
    Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
    López-Karpovitch X; Cárdenas R; Piedras J
    Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
    Motoji T
    Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotype of blast crisis in chronic myeloid leukemia].
    Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The onset of CML in blastic crisis: molecular features.
    Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
    J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.
    Leone G; La Rocca LM; Teofili L; De Candia E; Landolfi R; Sica S; Zini G; Zollino M; Tabilio A
    Haematologica; 1992; 77(4):311-4. PubMed ID: 1427440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
    Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
    Baryshnikov AIu; Turkina AG; Moiseenkova IN; Frolova EA; Sediakhina NP; Diagileva OA; Khoroshko ND; Mokeeva RA
    Ter Arkh; 1995; 67(7):22-5. PubMed ID: 7482298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases].
    Tassies D; Feliu E; Villamor N; Urbano-Ispizua A; Cervantes F; Campo E; Ordi J; Vernet M; Pujol R; López R
    Med Clin (Barc); 1990 Nov; 95(16):618-20. PubMed ID: 2097454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.